Back to search

PET Evidence That Loxapine Is an Equipotent Blocker of 5-HT2and D2Receptors: Implications for the Therapeutics of Schizophrenia

Data up to Jan 2025

Published1997
Citations96
References32

Total Citations Per Year

Abstract

References (32)

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

1992 • 1,420 citations

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

1989 • 1,313 citations

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1996 • 1,143 citations

Serotonin-dopamine interaction and its relevance to schizophrenia

1996 • 822 citations

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1984 • 701 citations

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1994 • 592 citations

Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors

1987 • 569 citations

Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.

1993 • 510 citations

Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors

1987 • 342 citations

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1995 • 341 citations

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1993 • 334 citations

The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.

1989 • 321 citations

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet study

1995 • 237 citations

Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.

1993 • 170 citations

D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

1995 • 143 citations

A Method for the In Vivo Investigation of the Serotonergic 5‐HT2 Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and 18F‐Labeled Setoperone

1990 • 110 citations

[18F]Setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo

1988 • 95 citations

The Role of Serotonin in Schizophrenia and the Place of Serotonin-Dopamine Antagonist Antipsychotics

1995 • 77 citations

Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain

1984 • 74 citations

Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells

1990 • 67 citations

Labeling of a serotoninergic ligand with 18F : [18F] setoperone

1988 • 46 citations

Therapeutic receptor-blocking concentrations of neuroleptics

1995 • 39 citations

Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis.

1996 • 38 citations

The D2 Receptor Occupancy Profile of Loxapine Determined Using PET

1996 • 37 citations

A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.

1996 • 35 citations

Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors

1983 • 32 citations

Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging

1997 • 30 citations

3H-spiroperidol binding to dopamine receptors in rat striatal membranes: Influence of loxapine and its hydroxylated metabolites

1979 • 26 citations

The role of metabolites in a bioequivalence study II: amoxapine, 7-hydroxyamoxapine, and 8-hydroxyamoxapine.

1999 • 21 citations

Measurement of [11C]Raclopride Binding Using a Bolus plus Infusion Protocol

1996 • 9 citations

A neurochemical basis for the antipsychotic activity of loxapine: Interactions with dopamine D1, D2, D4, and serotonin 5-HT2 receptor subtypes

1996 • 8 citations

Investigation of the Dopamine System with Positron Emission Tomography: General Issues in Modelling

1991 • 8 citations

Cited By (0)

Loading...
PET Evidence That Loxapine Is an Equipotent Blocker of 5-HT2and D2Receptors: Implications… (1997) – American Journal of Psychiatry | Metascience Observatory Explorer